BB Biotech AG | Ownership
Companies that own BB Biotech AG
The Vanguard Group, Inc.
1,391,005
2.5%
17,688
0%
07/31/2018
Degroof Petercam Asset Management SA
297,032
0.54%
-63,346
0.13%
02/28/2018
Bellevue Asset Management AG
252,600
0.46%
32,100
0.25%
07/31/2018
UBP-Gestion Institutionnelle SA
248,397
0.45%
-29,372
0.93%
12/31/2017
I.G. International Management Ltd.
227,162
0.41%
97,442
0.36%
03/31/2018
Arca Fondi SGR SpA
214,000
0.39%
49,000
0.14%
06/29/2018
Edinburgh Partners Ltd.
209,228
0.38%
-43,471
0.47%
06/30/2018
Alecta Pension Insurance Mutual
200,983
0.36%
200,983
0.03%
12/31/2017
AHL Partners LLP
184,625
0.33%
184,625
0.26%
06/30/2017
DWS Investment GmbH
161,846
0.28%
847
0.01%
09/06/2018
| Address |
Schwertstrasse 6
Schaffhausen Zurich 8200
Switzerland
|
|
Employees
|
- |
| Website |
http://www.bbbiotech.com |
| Updated |
09/14/2018 |
| BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on companies whose products address areas of significant unmet medical needs and generates above-average sales and profit growth. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland. |
